Gallstone disease. Disease of gallbladder, unspecified
Conditions
Interventions
Intervention 1: First Intervention group, Isofluran group: Isofluran 1.5% 1.5MAC inhalation in Anesthesia time. Intervention 2: Second Intervention group, Propofol group: Intravenous propofol infusion
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 80 Years
Inclusion criteria
Inclusion criteria: Age between 15 and 80 years old American Society of Anesthesiologists (ASA) Class I & II
Exclusion criteria
Exclusion criteria: History of allergic reaction to these medication Drug abuse Common Cold Heart and Renal diseases, Hypertension Taking tranquilizer medication Not signing informed consent to participate in the study Two failed attempts for Intubation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Pressure. Timepoint: Every 5 Minutes from beginning of intervention till the end of surgery. Method of measurement: Manometer.;Heart Rate. Timepoint: Every 5 Minutes from beginning of intervention till the end of surgery. Method of measurement: ECG Monitor.;Awakening time from anesthesia. Timepoint: When patient awakes and obeys. Method of measurement: Clinical Observation (Minutes).;Nausea & Vomiting. Timepoint: After patients awakening In recovery room. Method of measurement: Observe and record in a data form.;Hoarseness. Timepoint: After patients awakening In recovery room. Method of measurement: Observe and record in a data form.;Staying time in recovery room. Timepoint: After patients awakening In recovery room. Method of measurement: clinical, record in a data form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNader Toofani Shahraki
Zahedan University of Medical Sciences
Outcome results
None listed